Skip to content

CRISPR-edited Immortalized Knockout Cells

EditCo's Immortalized Cells offer robust and reproducible models for gene function studies, drug development, and therapeutic research. Delivering consistent performance and reliability, these cells accelerate scientific discovery by democratizing access to high-quality engineered cell lines.

Let's talk about how our Immortalized Cells can help your research.
Contact Us
Overview

Reliable, Reproducible Models for Accelerated Research

  • Invest in results: Spend your time running experiments, not generating your CRISPR knockouts.
  • Finish Experiments Faster: We’ll handle the CRISPR editing so you can run your assays sooner.
  • Assay with confidence: Trust your downstream assay results with EditCo’s incredibly high knockout efficiencies.
Knock-in Immortalized Cell Lines

We provide custom knockout edits for targeted gene disruption with advanced single-guide RNA, along with knockout pools and libraries leveraging our Multi-Guide Technology for maximum for gene disruption.

 

Accelerate Your Research with EditCo’s Knockout CRISPR Cell Lines

Creating genetically modified CRISPR knockout cells traditionally takes months and involves a high risk of failure. Our benchmark survey reveals that researchers invest an average of 61 hours in hands-on work before even isolating a clone, with 19.1 hours spent on optimization and 13.7 hours on transfection. EditCo's advanced automated optimization and transfection processes eliminate these time-consuming steps, enabling you to reclaim precious research hours. Transform your research workflow with EditCo’s knockout cells, and focus on achieving groundbreaking discoveries faster.

200 Ways We Optimize CRISPR to Achieve High Editing Across Cell Lines

EC-cell line optimization

EditCo’s 200-point optimization has been performed in over 100 human cell lines across 15 tissue types to identify the best parameters that yield the highest editing efficiency for each cell line.

 

EditCo’s Automated Immortalized Cell Line Editing Process

Cell Pools Clones Timeline

EC Pools overview-1M cells

Our gene editing workflow includes the use of our unique multi-guide design or single-guide transfection, genotyping, and sequencing analysis. Choose from either EditCo supplied cell lines banked from our high-quality cell supplier ATCC, or onboard your cells.

Characterize genes
Characterize Genes Associated with Neurodegenerative Disease: Develop immortalized cell line models to uncover and characterize genes involved in Parkinson’s Disease.
Protein mechanisms
Investigate a Protein’s Mechanism of Action: Accelerate your data generation with high-quality reagents that avoid high off-target issues to quickly and confidently confirm protein function.
Phenotype confirmation
Thoroughly Confirm Your Phenotype in Multiple Models in Parallel: Generate data in time for your next board meeting or publication by running assays in parallel to identify your targets.
Expedite drug discovery
Expedite Drug Discovery Research: Validate a new drug lead without having to invest time learning or optimizing CRISPR.
Multi-guide Express Cell Pools & Clones

Multi-guide Express Cell Pools & Clones

Generate Assay Results with Speed and Confidence

Express Cell Pools are highly knockout-edited pools of cells consisting of a heterogeneous population of edited and unedited cells for your gene of interest in human and mouse immortalized cell lines, generated in 2 weeks or sooner.

Whether you are leveraging CRISPR for validating targets for drug discovery or modeling a biological process for the investigation of a novel gene of interest, failed experiments lead to a loss of time and resources. EditCo’s Express Cell Pools are the solution for obtaining quick and reliable functional data while reducing the risk for false negatives in your critical assays.

Express Cell Pools workflow includes the use of our unique multi-guide design, transfection, genotyping, and sequencing analysis. Choose from either EditCo supplied cell lines banked from our high-quality cell supplier ATCC, or onboard your cells.

Features

Cell Source

  • EditCo supplied (standard)
  • Customer supplied

Available Edits

  • Single knockout
  • Cell pools

CRISPR Design

  • Multi-guide synthetic modified sgRNA (standard)

Add-Ons

  • Additional clones
  • Additional vials
  • Intermediate pools

Deliverables

  • Regular updates on your order's progress
  • 2 vials of edited cell pools (a heterogeneous population of edited and unedited cells) with >300,000 cells/vial
  • Control-transfected cell pools (2 vials)
  • Sequence of synthetic sgRNA used
  • Primer sequences used for NGS sequencing
  • NGS sequencing analysis report for each edited pool after expansion.
  • Comprehensive QC report that includes mycoplasma test (positive/negative) and passage number

Our Unique Guide Design Powers Functional Knockouts and Sustained Protein Depletion

Multi-giude schematic-new

Figure 1. The multi-guide approach consists of 3 gRNAs spatially coordinated to create a fragment deletion in a single exon. Targeting a single early exon of a gene induces multiple concurrent double-strand breaks in the target sequence of a gene. This results in disruptive one or more >21 bp fragment deletions. This approach is associated with higher frequencies of knockout alleles in edited pools but reduced occurrence of off-target edits as compared to single-guide approaches.

 

Hundreds of Diverse and Efficient Knockouts Generated in Under 4 Weeks

36 express pool cell lines

Figure 2. Express Cell Pools generated across 355 genes and 36 different cell lines in just 12 days. Using EditCo’s multi-guide designs, up to 3 modified gRNAs per target were conjugated with SpCas9, and RNPs were transfected into cells. On average, Express Knockout Cell Pools were generated in 12 days and achieved >80 percent Gene Knockout (Knockout Score percentage).

 

Sustained Gene Knockout Across Cell Passages

Sustained Express editing efficiency

Figure 3. High editing efficiency is sustained through multiple cell passages. Using EditCo’s multi-guide designs, up to 3 modified gRNA per target (across 6 genes) were conjugated with SpCas9, and RNPs were transfected into U2OS cells. Editing efficiencies were measured at different time points post-transfection and up to 4 passages. The median editing efficiency is >85 percent for each of the targets. 

 

Cell Viability Is Maintained Across Passages

Sustained Express viability

Figure 4. Cell viability is maintained through multiple cell passages in U2OS cells. Viability was taken using Celigo. Please note that CDK9 is a common essential gene, hence the lower viability and cell number observed along the passages.

 

Multi-guide KO Gel

Figure 5. Edited cell pools utilizing the multi-guide technology shows persistent protein depletion. This enables direct and reliable use of these cell pools for functional assays. Western blot analyses for all 5 knockout target genes indicate a complete depletion of proteins across the 3 specified time points (days 7, 14, and 21) relative to the negative controls. Knockout cell pools for the target genes were generated by nucleofecting U2OS cells with multi-guide sgRNA and Cas9 (as RNPs). A negative control pool was also transfected for each target using non-targeting sgRNA.

Single-guide RNA Knockout Cell Pools & Clones

Single-guide RNA Knockout Cell Pools & Clones

Accelerate Your Discoveries with Tailored CRISPR Knockout Cells

EditCo’s Knockout Immortalized Cell Pools and Clones provide reliable and efficient CRISPR solutions to accelerate your research, offering targeted gene disruption using advanced single-guide RNA technology for precise and impactful results. 

Pools of cells consist of a heterogeneous population of edited and unedited cells for your gene of interest, whereas clones refers to a single, genetically uniform population of cells derived from a parent cell.

Our cell pools achieve over 50% knockout efficiency, providing a ready-to-use mix of edited and unedited cells for immediate assay validation or clonal isolation, while our sequence-verified clonal populations deliver precise gene knockouts through a streamlined, fully optimized CRISPR-Cas9 process. With EditCo, you can focus on discoveries while we handle the complexities of CRISPR editing, offering both pools and clones to meet your research needs.

Features

Cell Source

  • EditCo supplied (standard)
  • Customer supplied

Available Edits

  • Indel (standard) or fragment deletion
  • Single, double, or triple knockout

CRISPR Design

  • Synthetic modified sgRNA (standard)

Add-Ons

  • Additional clones
  • Additional vials
  • Additional pools

Deliverables

  • Regular updates on your order's progress
  • Edited cell pools (2 vials with 5x10⁵ cells/vial)
  • Control-transfected cell pools (2 vials)
  • Sequence of synthetic sgRNA used
  • Primer sequences used for NGS sequencing
  • NGS sequencing analysis report for each edited pool after expansion.
  • Comprehensive QC report that includes the following information: mycoplasma test (positive/negative), passage number, and analysis for add-on QC

Sequencing deliverable note: For large fragment deletions and non-human/mouse cell types, an alignment between the Sanger sequencing data of the edited clone and the reference will be provided

Efficient Generation of Knockout Clones with Functional Outcomes

EditCo’s CRISPR Knockout Cell Clones eliminate the time and hassle of doing CRISPR editing and creating clonal cell lines so you can focus on your research.

KO clones web image

 

Validate your Assays with up to 95% Protein Knockout

EditCo’s Knockout Cell Pool gives you the protein knockout you need in the cell line you want, enabling you to either assay pools directly or quickly move to isolate single cell clones.

Gene Protein KO

 

Figure 6. EditCo’s Knockout Cell Pool achieved 95 percent protein knockout without clonal expansion. A cell pool with a surface protein knocked out was generated in U2OS cells with a Knockout Score of 87 percent (left panel, which is the percentage of indels that either introduce a frameshift mutation or are larger than 21 nucleotides, analyzed by ICE). Levels of this protein were analyzed by flow cytometry (blue) and were reduced by 95 percent relative to wild type (green, right panel). Negative control samples were stained with an isotype control antibody (purple). Data provided by Eurofins-DiscoverX.

Knockout Cell Libraries

Knockout Cell Libraries

Everything you need to get screening with Speed and Confidence

EditCo’s Engineered Cell Libraries simplify high-throughput CRISPR screening for functional assays, overcoming traditional barriers like infrastructure limitations and transfection challenges. 

 

These custom panels of knockout immortalized pools, designed using advanced multi-guide technology, achieve editing efficiencies over 90% and are provided in a ready-to-use 96-well arrayed format. With streamlined workflows, comprehensive QC reports, and compatibility with diverse downstream assays, our libraries empower you to confidently discover and validate drug targets at scale—letting you focus on your assay while we handle the CRISPR complexities.

Learn more about our Knockout iPSCs, also available as cell libraries.

Engineered Cell Libraries Process

The Engineered Cell Libraries workflow includes multi-guide design, high-throughput transfection, knockout pool generation, genotyping, and sequencing analysis.

Features

Cell Source

  • EditCo supplied 
  • Customer supplied

Available Edits

  • Single knockout cell pools

CRISPR Design

  • Multi-guide synthetic modified sgRNA (standard)

Deliverables

  • Regular updates on your order's progress
  • User-specified knockout cell pools per library (2 vials of each pool with ~20,000 cells/tube, 20 minimum order)
  • 5 control pools per rack: 2 mock WT, 2 multi-guide KO, 1 single-guide KO
  • Sequence of synthetic sgRNA used
  • Primer sequences used for PCR and Sanger Sequencing
  • ICE Sanger sequencing analysis reports
  • Comprehensive QC report that includes mycoplasma test (positive/negative) and passage number

Engineered Cell Libraries Demonstrate High Editing Efficiencies Across Cell Types

Engineered Cell Libraries provide a set of CRISPR-edited cell pools that can be used directly in functional assays for a wide array of different screening and discovery applications. Editing efficiencies for each pool are assessed by sequencing and ICE analysis to inform the interpretation of assay results.

Knockouts in Human Immortalized Cell Line

ECL Human KOs

Figure 1. A library of knockout cell pools corresponding to 42 gene targets was generated via high-throughput editing in human cells. Data from the experiment are shown above. An Engineered Cell Library with 42 gene targets was generated via high-throughput editing of an immortalized-adherent human cell line, A375, using multi-guide technology. The data demonstrate both indel frequencies and Knockout Scores. Of the 84 percent of pools successfully sequenced and analyzed, an average indel frequency of 99 percent and an average Knockout Score of 98 percent were observed.

 

Knockouts in Mouse Immortalized Cell Line

ECL Mouse KOs

Figure 2. A library of knockout cell pools corresponding to 192 gene targets was generated via high-throughput editing in mouse cells. The data demonstrate both indel frequencies and Knockout Scores. Among the 80 percent of pools successfully analyzed, the average indel frequency was 89 percent, while the average Knockout Score was 84 percent.

 

Our Unique Guide Design Powers Functional Knockouts and Sustained Protein Depletion

The multi-guide approach consists of up to 3 gRNAs (green bars) spatially coordinated that target a single early exon of a gene and induce multiple concurrent double-strand breaks in the target sequence. This results in disruptive one or more >21 bp fragment deletions. This approach is associated with higher frequencies of knockout alleles in edited pools but reduced occurrence of off-target edits as compared to single-guide approaches.

Multi-guide schematicFigure 3. The multi-guide approach consists of 3 gRNAs spatially coordinated to create a fragement deletion in a single exon. Targeting a single early exon of a gene induces multiple concurrent double-strand breaks in the target sequence of a gene. This results in disruptive one or more >21 bp fragment deletions. This approach is associated with higher frequencies of knockout alleles in edited pools but reduced occurrence of off-target edits as compared to single-guide approaches.

Multi-guide knockout gelFigure 4. Edited cell pools utilizing the multi-guide technology shows persistent protein depletion. This enables direct and reliable use of these cell pools for functional assays. Western blot analyses for all 5 knockout target genes indicate a complete depletion of proteins across the 3 specified time points (days 7, 14, and 21) relative to the negative controls. Knockout cell pools for the target genes were generated by nucleofecting U2OS cells with multi-guide gRNA and Cas9 (as RNPs). A negative control pool was also transfected for each target using non-targeting gRNA.

Resources

On-Demand Webinar
AI-driven Identification and Validation of Novel Synthetic Lethal Gene Pairs
Learn how EditCo Bio’s automated CRISPR platform is advancing drug discovery via Evariste's AI-driven platform.
Learn More
Application Note
CRISPR-Engineered Cells Enable Variant Disease Modeling
Understand how all researchers can leverage CRISPR-engineered cells to model multiple genetic variants and clones at scale.
Learn More
Flyer
Industrialized CRISPR Cells: CRISPR Done for You
EditCo's next-generation engineered cells provide researchers with access to the benefits of CRISPR. You no longer need to invest significant time and money to learn and optimize methods.
Learn More
flyer
Reimagine Genome Engineering
Customized CRISPR solutions to fit your research needs: Choose from do-it-yourself CRISPR options or CRISPR done for you.
Learn More
EditCo's Automated CRISPR Platform

Integrating our core CRISPR expertise, high-quality reagents, and automated processes, we deliver the best edited cell-based models at any scale.

CRISPR Engineered Cells Enable Variant Disease Modeling
Leveraging a sophisticated infrastructure with integration between bioinformatics, software, and automated platforms
Learn More
Automating biology and synergistic disciplines for streamlined cell editing and cell culture workflows
Learn More
Delivering experiment-ready edited cells for your next discoveries through a robust and cohesive ecosystem
Learn More
Lorem Overline

Testimonials consectitur amet sed

Lorem Button Text
Congue fermentum eros leo commodo. Integer vitae vitae ac amet. Vitae sed lectus vel lacus adipiscing nulla facilisis mauris porttitor. Viverra elementum odio vitae id.
placeholder-56x56
Albert Rose, Ph. D.
Principal Investigator, Boston Children's Hospital, Dana-Farber Cancer Institute, Harvard Medical School
Viverra aliquam volutpat interdum quisque vel mattis. Malesuada aliquam egestas pharetra a tempus ullamcorper egestas.
placeholder-56x56
Amanda Peyton, Ph. D.
Principal Investigator, Boston Children's Hospital, Dana-Farber Cancer Institute
Nibh luctus pulvinar sagittis faucibus commodo vitae purus. Ullamcorper dictum.
placeholder-56x56
Joseph James, Ph. D.
Principal Investigator, Boston Children's Hospital
Congue fermentum eros leo commodo. Integer vitae vitae ac amet. Vitae sed lectus vel lacus adipiscing nulla facilisis mauris porttitor. Viverra elementum odio vitae id.
placeholder-56x56
Albert Rose, Ph. D.
Principal Investigator, Boston Children's Hospital, Dana-Farber Cancer Institute, Harvard Medical School
Congue fermentum eros leo commodo. Integer vitae vitae ac amet. Vitae sed lectus vel lacus adipiscing nulla facilisis mauris porttitor. Viverra elementum odio vitae id.
placeholder-56x56
Albert Rose, Ph. D.
Principal Investigator, Boston Children's Hospital, Dana-Farber Cancer Institute, Harvard Medical School
Congue fermentum eros leo commodo. Integer vitae vitae ac amet. Vitae sed lectus vel lacus adipiscing nulla facilisis mauris porttitor. Viverra elementum odio vitae id.
placeholder-56x56
Albert Rose, Ph. D.
Principal Investigator, Boston Children's Hospital, Dana-Farber Cancer Institute, Harvard Medical School
Lorem Button Text

Lectus Pluristyx eu vel leo lectus mi. Viverra cursus neque eget proin.

Pellentesque nec tempus ultrices purus amet adipiscing aliquam. Posuere imperdiet adipiscing non blandit non. Sed eros vel sodales magna sem tincidunt orci risus. Molestie hendrerit cursus faucibus ac neque eget turpis. Arcu leo risus iaculis mi. Tortor bibendum sed cras pretium leo.

0+

Edits Performed

0+

Edits Performed

0+

Edits Performed
Lorem Overline

Lorem Ipsum Dolor Heading

Etiam sollicitudin, ipsum eu pulvinar rutrum, tellus ipsum laoreet sapien, quis venenatis ante odio sit amet eros. Duis arcu tortor, suscipit eget, imperdiet nec, imperdiet iaculis, ipsum. Maecenas nec odio et ante tincidunt tempus. Donec elit libero, sodales nec, volutpat a, suscipit non, turpis. Quisque id mi.

Lorem Button Text
Lorem Overline

Resources aliquam procte

Lorem Button Text
placeholder-280x160
Lorem overline
Ultrices nullam dictumst erat molestie massa a amet pulvinar bibendum lacus.
Tortor consectetur viverra malesuada dignissim duis quis. Morbi purus in velit lacus diam odio sed. Sed nisl arcu amet ut.
Read More
placeholder-280x160
Lorem overline
Ultrices nullam dictumst erat molestie massa a amet pulvinar bibendum lacus.
Tortor consectetur viverra malesuada dignissim duis quis. Morbi purus in velit lacus diam odio sed. Sed nisl arcu amet ut.
Read More
placeholder-280x160
Lorem overline
Ultrices nullam dictumst erat molestie massa a amet pulvinar bibendum lacus.
Tortor consectetur viverra malesuada dignissim duis quis. Morbi purus in velit lacus diam odio sed. Sed nisl arcu amet ut.
Read More
placeholder-280x160
Lorem overline
Ultrices nullam dictumst erat molestie massa a amet pulvinar bibendum lacus.
Tortor consectetur viverra malesuada dignissim duis quis. Morbi purus in velit lacus diam odio sed. Sed nisl arcu amet ut.
Read More
placeholder-280x160
Lorem overline
Ultrices nullam dictumst erat molestie massa a amet pulvinar bibendum lacus.
Tortor consectetur viverra malesuada dignissim duis quis. Morbi purus in velit lacus diam odio sed. Sed nisl arcu amet ut.
Read More
placeholder-280x160
Lorem overline
Ultrices nullam dictumst erat molestie massa a amet pulvinar bibendum lacus.
Tortor consectetur viverra malesuada dignissim duis quis. Morbi purus in velit lacus diam odio sed. Sed nisl arcu amet ut.
Read More
Lorem Button Text

Reach out to our experts to find out what EditCo can do for you.